Achillion Pharmaceuticals, Inc. (ACHN) Misses Q4 EPS by 2c; Guides FY12
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q4 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $62 thousand versus the consensus estimate of $120 thousand.
Sees FY2012 EPS of $-0.65-$-0.70, versus the consensus of $-0.64.
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Sees FY2012 EPS of $-0.65-$-0.70, versus the consensus of $-0.64.
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Quantinuum Inc (QNT) PT Raised to $95 at Bernstein SocGen Group
- Digital Brands Group forecasts positive cash flow starting in September
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
